Home › Interstitial Lung Diseases › New York › Rochester
Interstitial Lung Diseases clinical trials in Rochester, NY
4 studies for Interstitial Lung Diseases are looking for participants at sites in and around Rochester (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
RecruitingPhase 3
- University of Rochester Medical Center, Rochester
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RecruitingObservational study
- University of Rochester Medicine, Rochester
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
RecruitingPhase 2/3
- University of Rochester, Rochester
The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung Disease
Recruiting
- University of Rochester Medical Center, Rochester
About Interstitial Lung Diseases
Interstitial lung diseases are a group of diseases that inflame or scar the lungs. Breathing in particles (asbestosis, silicosis) causes some types.
More about Interstitial Lung Diseases on MedlinePlus
Interstitial Lung Diseases trials in other cities
- New York City, NY19 studies
- Philadelphia, PA17 studies
- Los Angeles, CA15 studies
- Kansas City, KS14 studies
- Houston, TX13 studies
- Durham, NC13 studies
- Charleston, SC13 studies
- Chicago, IL13 studies
- Ann Arbor, MI11 studies
- Aurora, CO11 studies
- Birmingham, AL10 studies
- Boston, MA10 studies
Other studies in Rochester
- Acute Myeloid Leukemia16 studies
- Cancer (all types)15 studies
- Breast Cancer15 studies
- Lung Cancer15 studies
- Obesity14 studies
- Overweight13 studies
- Non-Small Cell Lung Cancer13 studies
- Prostate Cancer10 studies
- Metastatic Cancer8 studies
- Multiple Myeloma8 studies
- Pancreatic Cancer7 studies
- Bladder Cancer7 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.